Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer-Reference-Cited by-同舟云学术

Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer

Published:2020 Issue:3 Volume:31 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Tate Shinichi¹^ORCID,Nishikimi Kyoko¹^ORCID,Kato Kazuyoshi²^ORCID,Matsuoka Ayumu¹^ORCID,Kambe Michiyo³^ORCID,Kiyokawa Takako⁴^ORCID,Shozu Makio¹^ORCID

Affiliation:

1. Department of Gynecology, Chiba University Hospital, Chiba, Japan.

2. Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan.

3. Department of Pathology, Nasional Hospital Organization Chiba Medical Center, Chiba, Japan.

4. Department of Pathology, Jikei University School of Medicine, Tokyo, Japan.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2020.31.e34

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-4 Cycles vs 6 Cycles NACT in Advanced Stage Epithelial Ovarian Cancer: Survival is not Determined by the Number of NACT Cycles;Chemotherapy;2023-12-19

2. Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis;Science Advances;2023-09-08

3. Do surgeons overestimate diaphragmatic peritoneal disease in interval debulking surgery of ovarian cancer?;European Journal of Surgical Oncology;2023-09

4. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study;Cancers;2023-08-26

5. Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer;BMC Surgery;2023-03-20